Cost Effectiveness of Cephalosporin Monotherapy and Aminoglycoside/ Ureidopenicillin Combination Therapy

This publication has 39 references indexed in Scilit:

• Pharmacoeconomic Comparison of Cefepime vs. Ceftazidime in Septic Patients
  Journal of Infectious Disease Pharmacotherapy, 1997
• Cost-Effectiveness of Ampicillin/Sulbactam Versus Imipenem/Cilastatin in the Treatment of Limb-Threatening Foot Infections in Diabetic Patients
  Clinical Infectious Diseases, 1997
• Cost-Effectiveness of Abbreviating the Duration of Intravenous Antibacterial Therapy with Oral Fluoroquinolones
  PharmacoEconomics, 1997
• Cost-Effectiveness Comparison of Cefepime and Ceftazidime Using Decision Analysis
  PharmacoEconomics, 1994
• Bacteremia Due to Viridans Streptococcus in Neutropenic Patients with Cancer: Clinical Spectrum and Risk Factors
  Clinical Infectious Diseases, 1994
• The costs of treating febrile neutropenia in six U.K. Hospitals
  European Journal Of Cancer, 1993
• Discounting in Cost-Effectiveness Analysis of Healthcare Programmes
  PharmacoEconomics, 1993
• From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus Panel
  The Journal of Infectious Diseases, 1990
• A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropenia
  New England Journal of Medicine, 1986
• Increasing incidence of gram‐positive sepsis in cancer patients
  Medical and Pediatric Oncology, 1978